Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (371-380 of 524) with videos related to

Pageof 53
Sort By:
Cell|September 7, 2024
TGF-β and RAS jointly unmask primed enhancers to drive metastasisJun Ho Lee, Francisco J Sánchez-Rivera, Lan He, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
First-in-human imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostateSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Cancer Discovery|May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancerRosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2020
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomasA J Schoenfeld, H Rizvi, C Bandlamudi, et al.
Clinical Lung Cancer|February 23, 2016
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and OutcomesJarushka Naidoo, Maria L Santos-Zabala, Tunc Iyriboz, et al.
Molecular Cancer Research : MCR|August 31, 2017
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung CancerZachary A Yochum, Jessica Cades, Lucia Mazzacurati, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic CharacterizationMarina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
Nature Reviews. Cancer|March 31, 2019
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Genome Medicine|November 16, 2022
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft libraryMichael Offin, Jennifer L Sauter, Sam E Tischfield, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Pageof 53

Showing results (371-380 of 524) with videos related to

Sort By:
Pageof 53
Cell|September 7, 2024
TGF-β and RAS jointly unmask primed enhancers to drive metastasisJun Ho Lee, Francisco J Sánchez-Rivera, Lan He, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
First-in-human imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostateSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Cancer Discovery|May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancerRosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2020
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomasA J Schoenfeld, H Rizvi, C Bandlamudi, et al.
Clinical Lung Cancer|February 23, 2016
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and OutcomesJarushka Naidoo, Maria L Santos-Zabala, Tunc Iyriboz, et al.
Molecular Cancer Research : MCR|August 31, 2017
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung CancerZachary A Yochum, Jessica Cades, Lucia Mazzacurati, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic CharacterizationMarina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
Nature Reviews. Cancer|March 31, 2019
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Genome Medicine|November 16, 2022
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft libraryMichael Offin, Jennifer L Sauter, Sam E Tischfield, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Pageof 53